fenton's reagent has been researched along with Breast Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baltić, VV; Bogdanović, G; Canadanović-Brunet, J; Dordević, A; Kojić, V; Vojinović-Miloradov, M | 1 |
Day, RO; Handel, ML; Sivertsen, S; Sutherland, RL; Watts, CK | 1 |
2 other study(ies) available for fenton's reagent and Breast Neoplasms
Article | Year |
---|---|
Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Electron Spin Resonance Spectroscopy; Female; Fullerenes; Humans; Hydrogen Peroxide; Hydroxyl Radical; Iron; Spin Trapping | 2004 |
D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA binding.
Topics: Breast Neoplasms; Cell Nucleus; Cysteine; DNA, Neoplasm; Female; Free Radicals; Humans; Hydrogen Peroxide; Iron; Kinetics; Nuclear Proteins; Penicillamine; Polydeoxyribonucleotides; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Transcription Factor AP-1; Tumor Cells, Cultured | 1996 |